This clinical trial is focused on studying gout, a type of arthritis that causes sudden and severe pain, redness, and swelling in the joints. The study will explore the effects of two medications, allopurinol and febuxostat, which are commonly used to lower uric acid levels in the body and help manage gout symptoms. These medications are taken orally in the form of tablets.

The purpose of the study is to determine whether stopping the use of these medications in patients whose gout is in remission, as monitored by ultrasound scans, is as effective as continuing the treatment in preventing future gout flares over a period of two years. Participants in the study will either continue their current medication or stop taking it, and their health will be monitored through regular check-ups and ultrasound scans to observe any changes in their condition.

The study will last for several years, with participants being observed at different intervals to track the occurrence of gout flares and other health indicators. The goal is to understand the long-term effects of maintaining or withdrawing urate-lowering therapy in patients with gout and to assess the impact on their overall health and quality of life. This research aims to provide valuable insights into the management of gout and help improve treatment strategies for patients in the future.